End Stage Renal Disease (ESRD) Clinical Trial
Official title:
Prospective Analysis of Hemodialysis Reliable Outflow (HeRO) Vascular Access Graft vs. Cuffed Catheter Access in Hemodialysis
The main objective of this research study was to compare the following outcomes between patients with a Hemodialysis Reliable Outflow (HeRO) Graft and patients with a cuffed catheter for dialysis access over one year: quality of life and incidence of bacteremia, vascular interventions, hospitalizations, and death.
All eligible participants who provided informed consent were included in the study.
Participants who refused HeRO Graft implantation, or did not have the HeRO Graft implanted
for any other reason, were followed in the control group. Several patients did not receive
the HeRO graft due to anatomical challenges and failure to complete both steps of the
two-stage implant procedure. All consented participants who had an implanted HeRO Graft were
followed in the study group. All participants were followed until the study end, withdrawal,
loss to follow-up, or death. The analysis included only HeRO Graft patients and control
patients who were not lost to follow-up; patients who were lost to follow-up, before data
collection, were excluded from analysis.
After obtaining Institutional Review Board (IRB) approval, baseline demographic and clinical
data was collected. Following surgery, implant procedure data was collected on study
participants who received HeRO Grafts. HeRO Grafts were placed using a 2-step process with
initial placement of the ePTFE portion, followed by completion of the graft by placement of
the venous outflow component. Following enrollment, outcomes of interest were collected at
follow-up visits scheduled weekly for 4 weeks, bi-weekly for 3 months, and monthly to 1
year, for a total of 18 follow-up visits. Study coordinators documented post-operative
complications, incidence of thrombosis, hospitalizations, infection incidents, and deaths at
each follow-up.
Quality of life data were also collected from all participants using the RAND Corporation's
Short Form (36) (SF-36) Health Survey. This survey was completed at enrollment and again at
3 months, 6 months, and 12 months.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05908084 -
To Compare the Efficacy and Safety of the HAV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
|
Phase 3 | |
| Active, not recruiting |
NCT05309109 -
Effect of Medium Cut-Off Hemodialysis on Protein Energy Wasting: The EMCOPEW Study
|
N/A | |
| Not yet recruiting |
NCT04086212 -
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
|
Phase 2 | |
| Completed |
NCT01783626 -
Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)
|
N/A | |
| Active, not recruiting |
NCT01693263 -
Outcome of BCF Access in Hemodialysis Patients
|
||
| Completed |
NCT01219959 -
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
|
Phase 3 | |
| Completed |
NCT02278341 -
Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
|
Phase 3 | |
| Completed |
NCT02593149 -
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
|
N/A | |
| Withdrawn |
NCT02274896 -
Bayston Multicenter Antimicrobial PD Catheter Safety Study
|
N/A | |
| Completed |
NCT04912050 -
EXtension of Tablo TrEatmeNt Duration Registry
|
||
| Recruiting |
NCT02745340 -
Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis
|
N/A | |
| Completed |
NCT02733328 -
Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
|
||
| Completed |
NCT04292184 -
Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation
|
Phase 1 | |
| Completed |
NCT02795286 -
Automated Setting of Individualized Sodium Technology
|
N/A | |
| Active, not recruiting |
NCT02808208 -
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
|
Phase 1/Phase 2 | |
| Completed |
NCT00559767 -
Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium
|
N/A | |
| Completed |
NCT02433210 -
A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients
|
N/A | |
| Completed |
NCT01594424 -
A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
|
Phase 1/Phase 2 | |
| Completed |
NCT05610683 -
Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers
|
N/A | |
| Completed |
NCT03249532 -
Effect of Dialysis Techniques on Blood Pressure and Cardiac Function During Dialysis
|
N/A |